These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. C6-ceramide in combination with transforming growth factor-β enhances Treg cell differentiation and stable FoxP3 expression in vitro and in vivo. Kue CS, Lim HX, Jung MY, Hong HJ, Cho D, Kim TS. Immunobiology; 2013 Jul; 218(7):952-9. PubMed ID: 23313049 [Abstract] [Full Text] [Related]
7. Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells. Klunker S, Chong MM, Mantel PY, Palomares O, Bassin C, Ziegler M, Rückert B, Meiler F, Akdis M, Littman DR, Akdis CA. J Exp Med; 2009 Nov 23; 206(12):2701-15. PubMed ID: 19917773 [Abstract] [Full Text] [Related]
11. Transforming growth factor-beta: an important role in CD4+CD25+ regulatory T cells and immune tolerance. Zhang L, Yi H, Xia XP, Zhao Y. Autoimmunity; 2006 Jun 23; 39(4):269-76. PubMed ID: 16891215 [Abstract] [Full Text] [Related]
12. The critical contribution of TGF-beta to the induction of Foxp3 expression and regulatory T cell function. Shevach EM, Tran DQ, Davidson TS, Andersson J. Eur J Immunol; 2008 Apr 23; 38(4):915-7. PubMed ID: 18395859 [Abstract] [Full Text] [Related]
14. TGF-β in transplantation tolerance. Regateiro FS, Howie D, Cobbold SP, Waldmann H. Curr Opin Immunol; 2011 Oct 23; 23(5):660-9. PubMed ID: 21839624 [Abstract] [Full Text] [Related]
15. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Dardalhon V, Awasthi A, Kwon H, Galileos G, Gao W, Sobel RA, Mitsdoerffer M, Strom TB, Elyaman W, Ho IC, Khoury S, Oukka M, Kuchroo VK. Nat Immunol; 2008 Dec 23; 9(12):1347-55. PubMed ID: 18997793 [Abstract] [Full Text] [Related]
16. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, McGrady G, Wahl SM. J Exp Med; 2003 Dec 15; 198(12):1875-86. PubMed ID: 14676299 [Abstract] [Full Text] [Related]
17. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4+CD25+Foxp3+ and CD4+CD25-Foxp3+ T cells. Polanczyk MJ, Walker E, Haley D, Guerrouahen BS, Akporiaye ET. J Transl Med; 2019 Jul 09; 17(1):219. PubMed ID: 31288845 [Abstract] [Full Text] [Related]
19. The Deubiquitinating Enzyme Ubiquitin-Specific Peptidase 11 Potentiates TGF-β Signaling in CD4+ T Cells to Facilitate Foxp3+ Regulatory T and TH17 Cell Differentiation. Istomine R, Alvarez F, Almadani Y, Philip A, Piccirillo CA. J Immunol; 2019 Nov 01; 203(9):2388-2400. PubMed ID: 31554694 [Abstract] [Full Text] [Related]
20. TGF-β Control of Adaptive Immune Tolerance: A Break From Treg Cells. Liu M, Li S, Li MO. Bioessays; 2018 Nov 01; 40(11):e1800063. PubMed ID: 30159904 [Abstract] [Full Text] [Related] Page: [Next] [New Search]